Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.81% | 174.66 | 1.2% | $575.79m | |
| CELG | Celgene Corporation | 0.60% | 89.49 | 1.2% | $535.84m | |
| GILD | Gilead Sciences, Inc. | 0.42% | 74.01 | 0.9% | $421.63m | |
| BIIB | Biogen Inc. | -1.41% | 259.30 | 1.2% | $416.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.56% | 316.01 | 2.7% | $245.42m | |
| INCY | Incyte Corporation | -0.42% | 68.14 | 2.5% | $245.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.34% | 158.69 | 1.9% | $226.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.05% | 107.83 | 2.0% | $209.17m | |
| NKTR | Nektar Therapeutics | -0.88% | 85.45 | 6.0% | $201.71m | |
| ILMN | Illumina, Inc. | 0.51% | 245.85 | 3.5% | $184.02m | |
| A | Agilent Technologies, Inc. | 0.74% | 68.05 | 1.5% | $157.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -1.66% | 95.86 | 9.8% | $140.19m | |
| BLUE | Bluebird Bio, Inc. | -1.32% | 168.25 | 15.8% | $127.75m | |
| EXAS | Exact Sciences Corporation | 2.48% | 48.70 | 25.7% | $111.34m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.27% | 82.08 | 4.4% | $104.77m |
Company Profile
Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.